These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 12112453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW, van den Anker JN.
    Ned Tijdschr Geneeskd; 2000 Nov 11; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract] [Full Text] [Related]

  • 4. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL.
    J Ark Med Soc; 2003 Dec 11; 100(6):203-6. PubMed ID: 14661403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Dec 11; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 8. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.
    Pediatrics; 2006 Jun 11; 117(6):2040-6. PubMed ID: 16740846
    [Abstract] [Full Text] [Related]

  • 9. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.
    Toxicol Lett; 2009 Jan 10; 184(1):38-43. PubMed ID: 19015014
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
    Rowe DL, Robinson PA, Gordon E.
    Clin Neurophysiol; 2005 Feb 10; 116(2):324-35. PubMed ID: 15661111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y, Doniger GM, Barak R, Simon ES, Hausdorff JM.
    J Child Neurol; 2007 Mar 10; 22(3):264-76. PubMed ID: 17621495
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr 10; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 19. [Phonological processing in children with attention deficit hyperactivity disorder: is methylphenidate effective?].
    Miranda-Casas A, Ygual-Fernández A, Mulas-Delgado F, Roselló-Miranda B, Bó RM.
    Rev Neurol; 2002 Feb 10; 34 Suppl 1():S115-21. PubMed ID: 12447801
    [Abstract] [Full Text] [Related]

  • 20. Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients.
    Goldman W, Seltzer R, Reuman P.
    Arthritis Rheum; 2008 Feb 10; 58(2):563-6. PubMed ID: 18240233
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.